产品货号 : mlR17682
英文名称 : SPOCD1
中文名称 : SPOCD1蛋白抗体
别 名 : FLJ25348; RP11-84A19.1; SPOC domain-containing protein 1; SPOC1_HUMAN; SPOCD1.
研究领域 : 肿瘤 细胞生物 免疫学 神经生物学
抗体来源 : Rabbit
克隆类型 : Polyclonal
交叉反应 : Human,
产品应用 : ELISA=1:500-1000 IHC-P=1:400-800 IHC-F=1:400-800 ICC=1:100-500 IF=1:100-500 (石蜡切片需做抗原修复)
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 : 130kDa
细胞定位 : 细胞核 细胞浆
性 状 : Lyophilized or Liquid
浓 度 : 1mg/ml
免 疫 原 : KLH conjugated synthetic peptide derived from human SPOCD1:361-450/1216
亚 型 : IgG
纯化方法 : affinity purified by Protein A
储 存 液 : 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存条件 : Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
PubMed : PubMed
产品介绍 : SPOCD1 is a 1,216 amino acid protein that contains one SPOC domain and one TFIIS central domain. SPOCD1 exists as five alternatively spliced isoforms, with isoform 1 showing expression in lung. The gene that encodes SPOCD1 contains 25,630 bases and maps to human chromosome 1p35.2. Spanning about 260 million base pairs and making up 8% of the human genome, chromosome 1 is the largest human chromosome. There are about 3,000 genes on chromosome 1, and considering the great number of genes there are also a large number of diseases associated with chromosome 1. Stickler syndrome, Parkinsons, Gaucher disease and Usher syndrome are also associated with chromosome 1 and aberrations in chromosome 1 are found in a variety of cancers including head and neck cancer, malignant melanoma and multiple myeloma.
Similarity:
Contains 1 SPOC domain.
Contains 1 TFIIS central domain.
SWISS:
Q6ZMY3
Gene ID:
90853
Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.